Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

Go back to Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
(NASDAQ: KALA) Delayed: 1.36 -0.03 (2.16%)
Previous Close $1.39    52 Week High
Open $1.41    52 Week Low
Day High $1.41    P/E N/A 
Day Low $1.30    EPS
Volume 36,390